– Dow Jones Citing WSJ
Skin Grafts Disruption: Avita Medical’s Regenerative Medicine System Poised to Disrupt Traditional Skin Grafts, Says Analyst
Cantor Fitzgerald has initiated coverage on Avita Medical Inc (NASDAQ: RCEL) at an Overweight rating and